#obesity-treatment

[ follow ]
#human-touch
News Center
4 weeks ago
Medicine

Tech Can't Replace Human Coaches in Obesity Treatment - News Center

Technology alone led to worse weight loss compared to tech and a telehealth coach. [ more ]
ScienceDaily
4 weeks ago
Wellness

Tech can't replace human coaches in obesity treatment

Technology alone insufficient for effective weight loss without human support. [ more ]
News Center
4 weeks ago
Medicine

Tech Can't Replace Human Coaches in Obesity Treatment - News Center

Technology alone led to worse weight loss compared to tech and a telehealth coach. [ more ]
ScienceDaily
4 weeks ago
Wellness

Tech can't replace human coaches in obesity treatment

Technology alone insufficient for effective weight loss without human support. [ more ]
morehuman-touch
#weight-loss-drugs
time.com
4 weeks ago
Medicine

A New Test Predicts Who Will Benefit Most from Weight-Loss Drugs

Genetic test MyPhenome can predict response to weight-loss drug semaglutide with 75% accuracy, categorizing people into four types of weight gain. [ more ]
www.npr.org
1 month ago
Wellness

Decades-old law limits access to Wegovy for Medicaid beneficiaries

Medicaid plans not required to cover Wegovy for weight loss/obesity, despite effectiveness, due to old law. [ more ]
www.nytimes.com
2 months ago
Wellness

Oprah Takes on Weight Stigma in the Ozempic Era

Weight loss drugs shift stigma around obesity and shame associated with dieting.
Patients feel shamed for using weight loss drugs, highlighting internal and external biases. [ more ]
www.bbc.com
3 days ago
Medicine

Top doctor alarmed by weight-loss drug misuse

NHS warns against the inappropriate use of weight-loss drugs without medical supervision. [ more ]
time.com
4 weeks ago
Medicine

A New Test Predicts Who Will Benefit Most from Weight-Loss Drugs

Genetic test MyPhenome can predict response to weight-loss drug semaglutide with 75% accuracy, categorizing people into four types of weight gain. [ more ]
www.npr.org
1 month ago
Wellness

Decades-old law limits access to Wegovy for Medicaid beneficiaries

Medicaid plans not required to cover Wegovy for weight loss/obesity, despite effectiveness, due to old law. [ more ]
www.nytimes.com
2 months ago
Wellness

Oprah Takes on Weight Stigma in the Ozempic Era

Weight loss drugs shift stigma around obesity and shame associated with dieting.
Patients feel shamed for using weight loss drugs, highlighting internal and external biases. [ more ]
www.bbc.com
3 days ago
Medicine

Top doctor alarmed by weight-loss drug misuse

NHS warns against the inappropriate use of weight-loss drugs without medical supervision. [ more ]
moreweight-loss-drugs
www.nature.com
1 month ago
OMG science

Daily briefing: Quantum internet' demonstrated in three cities

Researchers demonstrate quantum-entangled states in real urban areas, paving the way for a prototype quantum internet.
Combining a gut-hormone mimic with another molecule in obesity treatment shows promising results in animal experiments.
Lizard-inspired building design could enhance safety by isolating collapsing sections to prevent overall structure failure. [ more ]
english.elpais.com
1 month ago
OMG science

Diabetes drugs test a new side effect: slowing down symptoms of Parkinson's

GLP-1 receptor agonists have potential benefits beyond just treating diabetes and obesity, potentially impacting diseases like Alzheimer's and Parkinson's positively. [ more ]
BKReader
1 month ago
Medicine

10 Common Misconceptions About GLP-1 Weight Loss Drugs

GLP-1 drugs are effective but not instant weight loss solutions. They require lifestyle changes and patience for gradual, sustainable results. [ more ]
#fda-approval
Axios
3 months ago
Medicine

How Medicare can start covering a popular weight-loss drug for more people

Medicare may cover anti-obesity drug Wegovy for cardiovascular risks
Drug companies seek FDA approval for weight-loss drugs for various other conditions [ more ]
www.nytimes.com
3 months ago
Health

Wegovy Moves Beyond Weight Loss

Wegovy now approved for reducing cardiovascular risks in adults with heart disease and obesity
F.D.A. approval based on study showing Wegovy reduced heart attacks and strokes [ more ]
www.npr.org
3 months ago
Health

FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients

Weight-loss drug Wegovy approved to reduce cardiovascular risk in overweight patients.
Wegovy can lower the risk of heart attacks, strokes, and heart-related deaths in patients with obesity. [ more ]
Axios
3 months ago
Medicine

How Medicare can start covering a popular weight-loss drug for more people

Medicare may cover anti-obesity drug Wegovy for cardiovascular risks
Drug companies seek FDA approval for weight-loss drugs for various other conditions [ more ]
www.nytimes.com
3 months ago
Health

Wegovy Moves Beyond Weight Loss

Wegovy now approved for reducing cardiovascular risks in adults with heart disease and obesity
F.D.A. approval based on study showing Wegovy reduced heart attacks and strokes [ more ]
www.npr.org
3 months ago
Health

FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients

Weight-loss drug Wegovy approved to reduce cardiovascular risk in overweight patients.
Wegovy can lower the risk of heart attacks, strokes, and heart-related deaths in patients with obesity. [ more ]
morefda-approval
[ Load more ]